Watch Ticker

Rigel Pharmaceuticals Inc. (New)

Go to Rigel Pharmaceuticals Inc. (New) Website

$29.65

5.41 (22.32%)

Live

Previous Close

$29.81

Day Range

$26 - $30.4298

Previous Day Range

$21.87 - $24.849

Market Cap

$433.2 million USD

Day Vol.

2.3 million

Previous Day Vol.

1.2 million

Currency

USD

Primary Exchange

Nasdaq

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsi...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Jesterai - Rigel (RIGL) Q2 Revenue Jumps 176%

Rigel Pharmaceuticals exceeded Q2 2025 financial expectations with 176.4% revenue growth, driven by strong product sales and a significant Eli Lilly collaboration, raising full-year revenue guidance to $270-$280 million.

Related tickers: RIGL, LLY.

Read Full Article

N/A - Thérapeutique Knight annonce l’approbation réglementaire de TAVALISSE® au Mexique

Knight Therapeutics, a specialty pharmaceutical company, announced that its Mexican subsidiary has obtained regulatory approval from COFEPRIS for TAVALISSE® (fostamatinib) to treat adult patients with chronic immune thrombocytopenia (ITP) whose response to prior treatment was insufficient.

Related tickers: RIGL.

Read Full Article

Trending Tickers

Please sign in to view